Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL838P is a human pseudogene derived from the 7SL RNA, a component of the signal recognition particle (SRP), which normally guides the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotes. RN7SL838P is one of many 7SL-derived pseudogenes dispersed throughout the human genome, resulting from the insertion of reverse-transcribed 7SL RNA sequences into genomic DNA. Like other pseudogenes, RN7SL838P is considered nonfunctional: it does not encode a protein or a functional RNA and lacks regulatory elements required for significant biological activity. There is no evidence supporting a therapeutic or disease role for this pseudogene, nor is it considered a target for drug development, biomarker studies, or implicated in known safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 838, pseudogene (RN7SL838P).